How is symptomatic intracerebral hemorrhage after thrombolysis managed?

How is symptomatic intracerebral hemorrhage after thrombolysis managed?

• A. Halt anticoagulation, reverse coagulopathy if possible, manage ICP, monitor and involve neurology/neurosurgery.
• B. Increase anticoagulation to prevent re-occlusion.
• C. Ignore and monitor; no intervention.
• D. Proceed to immediate surgical evacuation in all cases.

Answer: (A)

When symptomatic intracerebral hemorrhage occurs after thrombolysis, the goal is to limit hematoma growth and protect brain tissue by stopping the thrombolytic effect, reversing the resulting coagulopathy, and providing supportive neurocritical care with specialist input. Start by halting the thrombolytic therapy and any ongoing anticoagulation. Quickly assess coagulation status and correct it: give cryoprecipitate to restore fibrinogen, and use rapid reversal with prothrombin complex concentrate to re-establish clotting factors; platelets are added if the patient is thrombocytopenic or has platelet dysfunction due to antiplatelet therapy. Manage intracranial pressure and cerebral perfusion with head-of-bed elevation, appropriate oxygenation, and blood pressure control per stroke/ICH guidelines; hyperosmolar therapy may be used if there are signs of rising ICP. Repeat imaging and close neuro-monitoring guide ongoing care. Involve neurology and neurosurgery early to determine whether surgical intervention is warranted based on hematoma size, location, and clinical trajectory—many cases are managed medically, with surgery reserved for select patients with substantial mass effect or deterioration.

When symptomatic intracerebral hemorrhage occurs after thrombolysis, the goal is to limit hematoma growth and protect brain tissue by stopping the thrombolytic effect, reversing the resulting coagulopathy, and providing supportive neurocritical care with specialist input. Start by halting the thrombolytic therapy and any ongoing anticoagulation. Quickly assess coagulation status and correct it: give cryoprecipitate to restore fibrinogen, and use rapid reversal with prothrombin complex concentrate to re-establish clotting factors; platelets are added if the patient is thrombocytopenic or has platelet dysfunction due to antiplatelet therapy. Manage intracranial pressure and cerebral perfusion with head-of-bed elevation, appropriate oxygenation, and blood pressure control per stroke/ICH guidelines; hyperosmolar therapy may be used if there are signs of rising ICP. Repeat imaging and close neuro-monitoring guide ongoing care. Involve neurology and neurosurgery early to determine whether surgical intervention is warranted based on hematoma size, location, and clinical trajectory—many cases are managed medically, with surgery reserved for select patients with substantial mass effect or deterioration.